Abstract
Neuroendocrine tumors of the pancreas today occupy the second place in the prevalence of malignant epithelial tumors of the pancreas [1, p. 132]. Neuroendocrine tumors are divided according to activity into functioning and non-functioning tumors, the latter in turn have the second name “non-secreting” and are more common than functioning tumors. Non-functioning tumors are unfavorable because their growth is slow and a person does not feel symptoms for a long time, but the tumor grows to large sizes, thereby causing symptoms of compression of adjacent anatomical structures [3, p.458]. Neuroendocrine tumors are often diagnosed when they have already metastasized or reached a large size. In view of this, assessment of the tumor load requires the use of several methods of radiation diagnostics: ultrasound, computed tomography, magnetic resonance imaging [2, p.30]. This article will review clinical cases of neuroendocrine tumors using different diagnostic methods.
Publisher
Non-profit limited company "Manash Kozybayev North Kazakhstan University"
Reference8 articles.
1. Andrej Dmitrievich Kaprin. Zlokachestvennye novoobrazovaniya v Rossii v 2017 godu (zabolevaemost' i smertnost') / Andrej Dmitrievich Kaprin. - MNIOI im. P.A. Gercena MNIOI im. P.A. Gercena-filial FGBU «NMIC radiologii» Minzdrava Rossii. - Moskva, 2018. - 250 s.
2. Gorbunova V.A., Orel N.F., Egorov G.N., Kuz'minov A.E. Vysokodifferencirovannye nejroendokrinnye opuholi (karcinoidy) i nejroendokrinnye opuholi podzheludochnoj zhelezy. - M.: Littera, 2007. - 104 s.
3. Kaltsas G.A., Besser G.M., Grossman A.B. The Diagnosis and medical management of advanced neuroendocrine tumors endocrine reviews 25 (3). - P. 458-511.
4. Axelrod L. Insulinoma: costeffective care in patients with a rare disease // Ann. Intern. Med. - 1995. - Vol. 123. - P. 311.
5. Santangelo W.C., O’Dorisio T.M., Kim J.C. et al. Vipoma syndrome: effect o f a synthetic somatostatin analogue // Scand. J. Gastroenter. - 1986. - Vol. 21 (Suppl. ll9). - P. 187-190.